MoneyWorks4Me

Gland Pharma informs about press release

29 Apr 2024 Evaluate

Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015; Gland Pharma has informed that it attached announcement regarding the receipt of US FDA approval for Cetrorelix Acetate for Injection, 0.25 mg/vial, Single-Dose Vial.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1759.90
Dr. Reddys Labs. 1228.00
Cipla 1306.75
Lupin 1944.05
Zydus Lifesciences 1123.90
View more..